Cleared Traditional

K904685 - EXEL HUBER INFUSION SET WITHOUT INJECTI...

K904685 is the FDA 510(k) clearance for EXEL HUBER INFUSION SET WITHOUT INJECTI... by Exel Intl.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 48-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1990
Decision
48d
Days
Class 2
Risk

K904685 is an FDA 510(k) clearance for the EXEL HUBER INFUSION SET WITHOUT INJECTION SITE (Y). Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Exel Intl. (Culver City, US). The FDA issued a Cleared decision on November 21, 1990 after a review of 48 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Exel Intl. devices

Submission Details

510(k) Number K904685 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 04, 1990
Decision Date November 21, 1990
Days to Decision 48 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 129d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 465
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K904685.
INTERLINK(TM) BLUNT CANNULA, MODIFICATION
K911868 · Baxter Healthcare Corp · Jun 1991
B-D SAFETY-LOK(TM) I.V. NEEDLES
K911136 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jun 1991
PIGGY LOCK NEEDLE HOUSING
K910546 · Icu Medical, Inc. · Apr 1991
STERILE I.V. START KIT
K902810 · Orion Life Systems, Inc. · Nov 1990
IN-LINE VIAL CONNECTION SITE
K900909 · Baxter Healthcare Corp · May 1990
ADVANCE CONTRAST MEDIA SETS (VARYING LENGTH)
K900187 · Advance Medical Designs, Inc. · May 1990